[A case of slowly progressive type 1 diabetes mellitus developing myeloperoxidase-specific anti-neutrophil cytoplasmic antibody-associated vasculitis with hypertrophic pachymeningitis manifesting as multiple cranial nerve palsy]
- PMID: 22214812
- DOI: 10.2177/jsci.34.510
[A case of slowly progressive type 1 diabetes mellitus developing myeloperoxidase-specific anti-neutrophil cytoplasmic antibody-associated vasculitis with hypertrophic pachymeningitis manifesting as multiple cranial nerve palsy]
Abstract
We report a 63-year-old man with a 35-year history of slowly progressive type 1 diabetes mellitus (SPIDDM), complicated with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis presenting alveolar hemorrhage and pachymeningitis. The patient was first diagnosed as having DM at age of 28 years old and deteriorated secretion of insulin and the typical clinical course led us to the diagnosis of SPIDDM. When he was 58 years old, he suffered from fever, headache, and alveolar hemorrhage. He was diagnosed as having MPO-ANCA associated vasculitis based on a high titer of MPO-ANCA and histological findings of lung biopsy. Treatment with steroid pulse therapy, followed by oral prednisolone and oral cyclophosohamide, resulted in clinical improvement. Five years later, he complained of double vision. A gadolinium-enhanced magnetic resonance imaging (MRI) study of the brain showed normal. Two months later, he developed right cranial nerve V~XII palsy. A second MRI study revealed thickening of the right temporal region and cerebellar dura mater, leading us to the diagnosis of hypertrophic pachymeningitis. He responded well to oral prednisolone (50 mg/day) and intravenous cyclophosohamide (500 mg). This is the first case report of SPIDDM complicated with MPO-ANCA-associated vasculitis, manifesting as alveolar hemorrhage and hypertrophic pachymeningitis.
Similar articles
-
[A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated hypertrophic pachymeningitis presenting with multiple cranial nerve palsies and diabetes insipidus].Rinsho Shinkeigaku. 2016 May 31;56(5):334-7. doi: 10.5692/clinicalneurol.cn-000859. Epub 2016 Apr 19. Rinsho Shinkeigaku. 2016. PMID: 27098904 Japanese.
-
[Unusual visual impairments in a case of MPO-ANCA associated hypertrophic pachymeningitis].Rinsho Shinkeigaku. 2012;52(3):152-5. doi: 10.5692/clinicalneurol.52.152. Rinsho Shinkeigaku. 2012. PMID: 22453038 Japanese.
-
Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis.Clin Rheumatol. 2010 Jan;29(1):111-3. doi: 10.1007/s10067-009-1269-x. Epub 2009 Sep 2. Clin Rheumatol. 2010. PMID: 19727912
-
Hypertrophic cranial pachymeningitis in MPO-ANCA-related vasculitis: a case report and literature review.Fukushima J Med Sci. 2013;59(1):56-62. doi: 10.5387/fms.59.56. Fukushima J Med Sci. 2013. PMID: 23842516 Review.
-
[A case of hypertrophic spinal pachymeningitis associated with MPO-ANCA].Rinsho Shinkeigaku. 2002 Sep;42(9):873-7. Rinsho Shinkeigaku. 2002. PMID: 12710088 Review. Japanese.
Cited by
-
Pachymeningitis as a manifestation of ANCA-associated vasculitis: a care report and literature review.Int J Clin Exp Med. 2015 Apr 15;8(4):6352-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131256 Free PMC article.
-
Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis.Clin Rheumatol. 2019 Apr;38(4):1039-1046. doi: 10.1007/s10067-018-4372-z. Epub 2018 Nov 27. Clin Rheumatol. 2019. PMID: 30483978
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous